| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/22/2007 | US20070041998 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 02/22/2007 | US20070041997 Bacterial virulence factors and uses thereof |
| 02/22/2007 | US20070041987 Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development |
| 02/22/2007 | US20070041986 Synthetic polysaccharide antigens for immunological intervention in disease |
| 02/22/2007 | US20070041985 Modulation of the poliovirus receptor function |
| 02/22/2007 | US20070041976 Treating septic arthritis; Interleukin-4 (IL-4), previously known as B cell stimulating factor |
| 02/22/2007 | US20070041975 Homogeneous preparations of il-28 and il-29 |
| 02/22/2007 | US20070041974 Cytokine zalpha11 ligand antibodies |
| 02/22/2007 | US20070041973 Compositions and methods for treating, preventing and/or reversing type-1 diabetes |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041969 Apo-2DcR |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041962 Method of promoting healing of a tympanic membrane perforation |
| 02/22/2007 | US20070041961 Ultrasound target vessel occlusion using microbubbles |
| 02/22/2007 | US20070041960 Apparatus and methods for enzymatic debridement of skin lesions |
| 02/22/2007 | US20070041959 polymer conjugated polypeptide contains polyoxyethylene glycol binding to a Kunitz domain which specifically binds and/or inhibits a protease; modified protease inhibitors; increase the molecular weight of the compound |
| 02/22/2007 | US20070041958 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 02/22/2007 | US20070041957 Stimulating formation of an inner ear sensory hair cell for treatment of sensorineuronal hearing loss; deafness |
| 02/22/2007 | US20070041956 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2007 | US20070041955 Hedgehog signaling promotes the formation of three dimensional cartilage matrices |
| 02/22/2007 | US20070041951 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof |
| 02/22/2007 | US20070041945 Novel method for down-regulation of amyloid |
| 02/22/2007 | US20070041940 Methods of treating cancer using il-21 |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041938 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 02/22/2007 | US20070041937 G-csf derivative for inducing immunological tolerance |
| 02/22/2007 | US20070041936 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2619721A1 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 02/22/2007 | CA2619716A1 Antigenic peptides and their use |
| 02/22/2007 | CA2619650A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 02/22/2007 | CA2619593A1 Stem cell derived factors for treating pathologic conditions |
| 02/22/2007 | CA2619577A1 Gene disruptions, compositions and methods relating thereto |
| 02/22/2007 | CA2619303A1 Dental composition comprising enzyme |
| 02/22/2007 | CA2619017A1 Gdnf derived peptides |
| 02/22/2007 | CA2618958A1 Use of peptides that bind to tpo receptor |
| 02/22/2007 | CA2618951A1 Mcp1 fusions |
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2618740A1 Selective vpac2 receptor peptide agonists |
| 02/22/2007 | CA2618561A1 A process for the preparation of perindopril erbumine |
| 02/22/2007 | CA2618508A1 Truncated memapsin 2 for use for treating alzheimer's disease |
| 02/22/2007 | CA2618439A1 Technique for stabilization of yw753 reparation |
| 02/22/2007 | CA2617958A1 Peg-ifn alpha and ribavirin for hbv treatment |
| 02/22/2007 | CA2616393A1 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20 |
| 02/22/2007 | CA2615636A1 Treatment of diseases by subcutaneous administration of a vegf antagonist |
| 02/22/2007 | CA2556473A1 Canine tumor treatment method, pharmaceutical formulation applied thereto, and method of cryogenically preserving cells used therewith |
| 02/21/2007 | EP1754718A2 Inactivation resistant factor VIII |
| 02/21/2007 | EP1754717A1 Antigenic peptides and their use |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754713A1 apo2l (trail) receptor binding peptides and uses thereof |
| 02/21/2007 | EP1754490A2 CD 154 blockage therapy for pancreatic islet tissue transplantation in primates |
| 02/21/2007 | EP1754489A1 A method of treating vitiligo using synergistic formation |
| 02/21/2007 | EP1754488A1 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 02/21/2007 | EP1754487A1 Modulators of the Melted protein and uses thereof |
| 02/21/2007 | EP1754485A1 Remedy for neurodegenerative diseases |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1754464A1 Enzyme comprising dental composition |
| 02/21/2007 | EP1753997A1 Photochromic material comprising a proteorhodopsin apoprotein and retinal analog |
| 02/21/2007 | EP1753782A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 02/21/2007 | EP1753781A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/21/2007 | EP1753779A2 Interferon-alpha polypeptides and conjugates |
| 02/21/2007 | EP1753776A1 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents |
| 02/21/2007 | EP1753615A2 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer |
| 02/21/2007 | EP1753478A1 Medical device comprising a biologically active agent |
| 02/21/2007 | EP1753458A2 Modulation of immunoglobulin production and atopic disorders |
| 02/21/2007 | EP1753456A2 Methods for treating conditions associated with masp-2 dependent complement activation |
| 02/21/2007 | EP1753452A2 A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor |
| 02/21/2007 | EP1753451A2 Local delivery of growth factors for stem cell transplantation |
| 02/21/2007 | EP1753450A1 Process for the isolation and/or purification of proteins |
| 02/21/2007 | EP1753449A2 Methods and compositions for control of fetal growth via modulation of relaxin |
| 02/21/2007 | EP1753448A2 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 02/21/2007 | EP1753447A2 Immune response suppressor and treatment of multiple sclerosis |
| 02/21/2007 | EP1753446A2 Alpha-1- acid glycoprotein for the treatment of diabetes |
| 02/21/2007 | EP1753445A2 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 02/21/2007 | EP1753444A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition therefor in form of a kit |
| 02/21/2007 | EP1753443A1 Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition |
| 02/21/2007 | EP1753442A2 Method of administering and using vegf inhibitors for the treatment of human cancer |
| 02/21/2007 | EP1753441A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/21/2007 | EP1753409A2 Dosage form containing the active ingredient cholylsarcosine |
| 02/21/2007 | EP1753291A2 Methods for controlling angiogenesis and cell proliferation |
| 02/21/2007 | EP1608685B1 Vegf antagonists for the treatment of diabetes |
| 02/21/2007 | EP1592702A4 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 02/21/2007 | EP1578955A4 Candida kefyr cytosine deaminase |
| 02/21/2007 | EP1532163A4 Androgen receptor coregulators |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1520018B1 Process for producing a virus-inactivated thrombin preparation |
| 02/21/2007 | EP1515983B1 Antibacterial amide macrocycles |
| 02/21/2007 | EP1414316B1 Nutritional composition preventing bacterial overgrowth |
| 02/21/2007 | EP1357901B1 Process for preparing particles |
| 02/21/2007 | EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 02/21/2007 | EP1290137B1 Virulence genes, proteins, and their use |
| 02/21/2007 | EP1280545B1 Cross-linked collagen matrices and methods for their preparation |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1231279B1 Process for producing tripeptides |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1161524B1 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN $g(a)-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS |
| 02/21/2007 | EP1135503B1 Drug targets in candida albicans |
| 02/21/2007 | EP1104438B1 Novel anti-diabetic peptides |
| 02/21/2007 | EP1100819B1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |